Ajay Kolli1,2, Michelle M Hood3, Carrie Karvonen-Gutierrez3, Sayoko E Moroi4,5, Joshua R Ehrlich4,6, Brenda W Gillespie7, Sarah Dougherty Wood4, David C Musch3,4. 1. University of Michigan Medical School, University of Michigan, Ann Arbor, USA. 2. Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA. 3. Department of Epidemiology, University of Michigan School of Public Health, University of Michigan, Ann Arbor, USA. 4. Department of Ophthalmology and Visual Sciences, Michigan Medicine, University of Michigan, Ann Arbor, USA. 5. Department of Ophthalmology and Visual Sciences, Ohio State University Wexner Medical Center, The Ohio State University, Columbus, USA. 6. Institute for Social Research, University of Michigan, Ann Arbor, USA. 7. Department of Biostatistics, University of Michigan School of Public Health, University of Michigan, Ann Arbor, USA.
Abstract
BACKGROUND: In older adults, vision impairment (VI) is associated with worse cognitive function. However, the relationship between midlife vision and future cognitive function remains unknown. METHODS: The Study of Women's Health Across the Nation, Michigan site, is a longitudinal cohort of midlife women aged 42-52 years at baseline. Presenting Titmus visual acuity (VA) in the better-seeing eye was assessed at baseline and categorized as no or mild VI (VA ≥20/60), or moderate or worse VI (VA <20/60). Cognitive function was measured 8 times over 15 years using the East Boston Memory Test immediate (EBMTi) and delayed (EBMTd) recall and the Digit Span Backwards (DSB) test. Linear mixed models with a random intercept and slope for age were constructed to detect associations between VI at baseline and future repeated measures of cognitive function, adjusting for age, race, education, financial strain, alcohol use, and tobacco use. RESULTS: About 394 women aged 42-52 at baseline with a maximum follow-up of 20 years were included in this analysis. After covariate adjustment, moderate or worse VI was associated with lower EMBTi (β = -0.56, p = .012), EBMTd (β = -0.60, p = .009), and DSB (β = -0.84, p = .04). While we detected significant associations between VI and levels of cognitive function scores, rates of cognitive decline as individuals aged did not vary by VI status. CONCLUSION: Moderate or worse VI, assessed during midlife, was associated with lower scores on measures of cognitive function over a 15-year period during which women transitioned from midlife to older adulthood.
BACKGROUND: In older adults, vision impairment (VI) is associated with worse cognitive function. However, the relationship between midlife vision and future cognitive function remains unknown. METHODS: The Study of Women's Health Across the Nation, Michigan site, is a longitudinal cohort of midlife women aged 42-52 years at baseline. Presenting Titmus visual acuity (VA) in the better-seeing eye was assessed at baseline and categorized as no or mild VI (VA ≥20/60), or moderate or worse VI (VA <20/60). Cognitive function was measured 8 times over 15 years using the East Boston Memory Test immediate (EBMTi) and delayed (EBMTd) recall and the Digit Span Backwards (DSB) test. Linear mixed models with a random intercept and slope for age were constructed to detect associations between VI at baseline and future repeated measures of cognitive function, adjusting for age, race, education, financial strain, alcohol use, and tobacco use. RESULTS: About 394 women aged 42-52 at baseline with a maximum follow-up of 20 years were included in this analysis. After covariate adjustment, moderate or worse VI was associated with lower EMBTi (β = -0.56, p = .012), EBMTd (β = -0.60, p = .009), and DSB (β = -0.84, p = .04). While we detected significant associations between VI and levels of cognitive function scores, rates of cognitive decline as individuals aged did not vary by VI status. CONCLUSION: Moderate or worse VI, assessed during midlife, was associated with lower scores on measures of cognitive function over a 15-year period during which women transitioned from midlife to older adulthood.
Authors: R N Bailey; R W Indian; X Zhang; L S Geiss; M R Duenas; J B Saaddine Journal: MMWR Morb Mortal Wkly Rep Date: 2006-12-15 Impact factor: 17.586
Authors: Brenda L Plassman; Kenneth M Langa; Gwenith G Fisher; Steven G Heeringa; David R Weir; Mary Beth Ofstedal; James R Burke; Michael D Hurd; Guy G Potter; Willard L Rodgers; David C Steffens; John J McArdle; Robert J Willis; Robert B Wallace Journal: Ann Intern Med Date: 2008-03-18 Impact factor: 25.391
Authors: Shicheng Jin; Graham E Trope; Yvonne M Buys; Elizabeth M Badley; Kednapa Thavorn; Peng Yan; Harrish Nithianandan; Ya-Ping Jin Journal: PLoS One Date: 2019-07-23 Impact factor: 3.240
Authors: Line Jee Hartmann Rasmussen; Avshalom Caspi; Antony Ambler; Jonathan M Broadbent; Harvey J Cohen; Tracy d'Arbeloff; Maxwell Elliott; Robert J Hancox; HonaLee Harrington; Sean Hogan; Renate Houts; David Ireland; Annchen R Knodt; Kim Meredith-Jones; Miriam C Morey; Lynda Morrison; Richie Poulton; Sandhya Ramrakha; Leah Richmond-Rakerd; Maria L Sison; Kate Sneddon; W Murray Thomson; Ahmad R Hariri; Terrie E Moffitt Journal: JAMA Netw Open Date: 2019-10-02
Authors: Joshua R Ehrlich; Bonnielin K Swenor; Yunshu Zhou; Kenneth M Langa Journal: J Gerontol A Biol Sci Med Sci Date: 2021-11-15 Impact factor: 6.591